Related Experiment Videos
Comparison of activity of sisomicin and gentamicin in mouse protection tests with gram-negative bacilli
Abstract:
The efficacy of sisomicin and gentamicin was compared in mouse protection studies against strains of Escherichia coli, Klebsiella sp., Enterobacter aerogenes, Serratia marcescens, Proteus mirabilis, and Pseudomonas aeruginosa. There was no significant difference in mortality of the mice in any of the protocol groups when five different dosages of sisomicin and gentamicin given by three separate schedules were compared for each bacterial inoculum in each antibiotic protocol. The mean protective dose values of sisomicin were at least one-half those of gentamicin for each protocol against Pseudomonas aeruginosa.
Insights
Sisomicin and gentamicin showed similar efficacy in protecting mice against common bacterial infections. However, sisomicin demonstrated greater potency against Pseudomonas aeruginosa in these comparative studies.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance is a growing global health concern.
- Aminoglycosides like gentamicin and sisomicin are crucial for treating serious bacterial infections.
- Comparative efficacy studies are vital for optimizing antibiotic selection.
Purpose of the Study:
- To compare the in vivo efficacy of sisomicin and gentamicin.
- To evaluate their effectiveness against a range of Gram-negative bacteria.
- To determine potential differences in protective dosing.
Main Methods:
- Mouse protection studies were conducted.
- Inoculums of Escherichia coli, Klebsiella sp., Enterobacter aerogenes, Serratia marcescens, Proteus mirabilis, and Pseudomonas aeruginosa were used.
- Five dosages and three administration schedules for each antibiotic were tested.
Main Results:
- No significant difference in mouse mortality was observed between sisomicin and gentamicin across most bacterial strains and protocols.
- Sisomicin exhibited at least half the mean protective dose of gentamicin against Pseudomonas aeruginosa.
- This suggests a potentially higher potency of sisomicin against this specific pathogen.
Conclusions:
- Sisomicin and gentamicin exhibit comparable efficacy in mouse models for many Gram-negative infections.
- Sisomicin may be more potent than gentamicin specifically against Pseudomonas aeruginosa infections.
- Further clinical studies could clarify the therapeutic utility of sisomicin.